Dr. Reddy is board certified in internal medicine, medical oncology, and hematology. He has practiced medicine and served in leadership positions for more than 10 years in various clinical settings including academia, private practice, and managed care. Dr. Prasanth Reddy sits down with Kevin Keegan, General Manger, Oncology at Illumina to talk about what it takes to support world-class-diagnostics to compliment and augment treatment choices whether standard of care or in clinical trials. Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM Facebook: facebook.com/illuminainc LinkedIn: linkedin.com/company/illu... Instagram: instagram.com/illuminainc Twitter: twitter.com/illumina #HumanHealth #Genomics #GenomeEra #Illumina #LabCorp #DemocratizationOfTesting #Evidence #Partnership #IGF #IlluminaGenomicsForum #LightboxConversations